SphereBio
Developer of a biotech delivery platform that combines bioinformatics, synthetic virology, and nanotechnology to design and deliver patient-specific molecules that train immune cells for personalized cancer vaccines and immunotherapies. The organization focuses on tumor profiling, custom therapeutic design, and collaborative development with pharmaceutical and academic partners.
Industries
Nr. of Employees
small (1-50)
Products
Biotech delivery platform for personalized therapeutics
A platform that delivers computationally designed molecular payloads to cells, intended to train immune responses and enable personalized cancer vaccines.
Biotech delivery platform for personalized therapeutics
A platform that delivers computationally designed molecular payloads to cells, intended to train immune responses and enable personalized cancer vaccines.
Services
Design and development of patient-specific vaccine candidates and therapeutic molecules informed by tumor bioinformatics.
Provision or development of delivery-system technology combining synthetic virology and nanotechnology to transport designed payloads into cells.
Design and development of patient-specific vaccine candidates and therapeutic molecules informed by tumor bioinformatics.
Provision or development of delivery-system technology combining synthetic virology and nanotechnology to transport designed payloads into cells.
Expertise Areas
- Personalized cancer vaccine development
- Bioinformatics for tumor profiling
- Delivery platform development (synthetic virology + nanotechnology)
- Therapeutic payload design
Key Technologies
- Bioinformatics algorithms for tumor analysis
- Synthetic virology techniques
- Nanotechnology-based delivery systems
- Personalized vaccine design
News & Updates
Press coverage noting plans or ambitions to conduct medical trials in collaboration with Harvard (as reported by a news article linked on the site).
Article describing how the company's technology is used to create personalized cancer vaccines (external coverage linked from site).
Press article covering the startup's development of vaccines for cancer treatment.
Article noting external recognition of the company's platform by MIT-related programs.
Press mention in coverage of Argentine startups and health-focused innovation.
Listicle referencing the company among notable Argentine startups.
Press coverage noting plans or ambitions to conduct medical trials in collaboration with Harvard (as reported by a news article linked on the site).
Article describing how the company's technology is used to create personalized cancer vaccines (external coverage linked from site).
Press article covering the startup's development of vaccines for cancer treatment.
Article noting external recognition of the company's platform by MIT-related programs.
Press mention in coverage of Argentine startups and health-focused innovation.
Listicle referencing the company among notable Argentine startups.